Trial Profile
A Randomized, Open-label, Active-controlled, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride (HCl) Formulation Versus 5% Amorolfine Nail Lacquer for 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2014
Price :
$35
*
At a glance
- Drugs Terbinafine (Primary) ; Amorolfine
- Indications Onychomycosis
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 27 May 2014 New trial record